February 2014

Device created using printer may predict heart attacks ()
BP differences between arms may increase cardiovascular risk ()
FDA approves catheter for AF ablation ()
Costs vary widely across hospitals for congenital heart operations ()
AHA panel: Depression should be risk factor ()
CT-based imaging on the rise in ischemic stroke patients ()
Acting on evidence and its absence ()
Cordis Corporation receives CE Mark for RENLANE renal denervation system to treat resistant hypertension ()
The Montreal Heart Institute will pilot ARTERIA: a major research program for patients with or at risk of cardiovascular diseases ()
'I am CardioSmart' contest recognizes coronary artery disease patient ()
Scripps Clinic first to implant miniature cardiac monitor ()
OrbusNeich initiates HARMONEE study in Japan to evaluate the COMBO(tm) dual therapy stent ()
Study challenges FDA’s stance on CT risks to implanted devices ()
Report says less favorable Pradaxa data withheld from FDA ()
Value drives next steps in imaging lab accreditation ()
Transfusion practices in PCI: A bloody mess? ()
Calcification may lead to poor prognosis after NSTEACS and STEMI ()
FDA recalls guidewires used in cath procedures ()
1 in 5 eligible ACS patients not receiving ACEI/ARBs ()
Bereavement may up risk of heart attack, stroke ()
BP meds may put elderly at risk for serious fall injuries ()
High-potency statins may lower mortality risk after heart attacks ()
Think green: Meta-analysis sees BP benefit in plant-based diets ()
Morphine may diminish clopidogrel’s effect ()
Compound improves cardiac function in mice with genetic heart defect, MU study finds ()
American Heart Association awards Loyola $438,740 for cardiac research ()
Medtronic enrolls first U.S. patient in global clinical trial for miniature transcatheter pacemaker system ()
FDA and European Medicines Agency strengthen collaboration in pharmacovigilance area ()
Christiana Care Health System launches patient navigator program to keep patients healthy after they leave hospital ()
Robotic-assisted coronary angioplasty procedures will be highlighted during CRT2014 conference in Washington, D.C. ()
UAB cardiologists implant subcutaneous defibrillator in first Alabama patient ()
Risk calculator available as free mobile app ()
Statins may improve survival for patients with critical limb ischemia ()
Use clinical judgment when guidelines differ ()
Temporarily stopping anticoagulation with AF common but risky ()
Surgical teamwork may explain volume-outcome differences ()
Texas Cardiac Arrhythmia Institute at St. David’s Medical Center to host EP Live 2014 ()
CMS will cover cardiac rehab for HF patients ()
Signs of myocardial injury after surgery often missed ()
When patients see only stars ()
Online doctor reviews sway third of site users ()
Cardiologist Victor Dzau to lead IOM ()
Genotyping makes some antiplatelet therapy more cost-effective ()
RAAFT-2 favors ablation over drugs but highlights risks ()
ACC.14: Addressing the business side of cardiology ()
TAVR offers only modest benefits in some realms ()
NICE backs lower-risk threshold for statin treatment ()
USPSTF: No screening for asymptomatic carotid artery stenosis ()
Million Hearts: Aching at the midpoint? ()
OIG targets cardiac caths, biopsies for review ()
Intracranial atherosclerosis may be major stroke predictor ()
Dronedarone guidelines may be short on evidence ()
Partners HealthCare at Home strengthens services with Philips ()
UTHealth, Memorial Hermann perform state’s first conscious sedation TAVR procedure ()
Medtronic launches 'total across' crossing catheter in Europe ()
FDA panel gives cangrelor a no-go ()
2,000 patients suing Boehringer over Pradaxa ()
Postpartum thrombotic risk extends to 12 weeks ()
Progress & concerns ()
Advocate Sherman Hospital selected for American College of Cardiology Patient Navigator Program ()
Weather extremes may trigger stroke ()
Recent cocaine use amplifies stroke risk in the young ()
Cardiac imaging dose should prompt talk with patient ()
PCI victory? More die from non-cardiac causes post-procedure ()
Saxagliptin’s heart failure finding prompts FDA review ()
Docs’ outlook brightens with employer-provided intervention ()
Aegerion Pharmaceuticals' JUXTAPID (lomitapide) capsules approved in Canada for the treatment of homozygous familial hypercholesterolemia (HoFH) ()
Hospitals vary in use of noninvasive cardiac imaging ()
Lower-intensity statin combo may benefit high-risk patients ()
List helps EPs steer clear of inappropriate care ()
Report: Device makers’ computer systems hacked ()
ACOs & cardiology: Trend hints at some alignment ()
Online ‘heart age’ tool may lower CVD risk ()
Society to docs: Discuss testosterone therapy’s risk with patients ()
Boston Scientific launches OffRoad Re-Entry Catheter System ()
Society of Cardiovascular Computed Tomography (SCCT) is now accepting submissions for the 8th annual Toshiba Young Investigator Awards (YIA) ()
25% of diagnostic caths in N.Y. considered inappropriate ()
eCardio opens independent diagnostic testing facility in California ()
AstraZeneca HealthCare Foundation awards $197,634 grant to Saint Agnes Hospital Foundation ()
AstraZeneca HealthCare Foundation awards $213,094 grant to Christiana Care Health System ()
Esaote brings leading TAVR software to USA and Canada ()
First leadless pacemaker in United States implanted into a patient at the Mount Sinai Hospital ()
Edwards' SAPIEN XT valve approved in Europe for transcatheter mitral and aortic valve-in-valve procedures ()
Merge's Cardiology PACS named best in KLAS, hemodynamic solution ranked category leader third consecutive year ()
Neovasc Inc. announces successful first human implant of Tiara transcatheter mitral valve ()
Guidelines focus on stroke prevention in women ()
Corporate coups ()
Topol joins AT&T as chief medical adviser ()
Intervention may improve post-ACS medication adherence ()
FDA rulemaking process lacks transparency, efficiency ()
MRI may help identify best candidates for ablation ()
Heart societies hail CVS decision to end tobacco sales ()
Early BP changes may signal risk for CAC ()
Some durable-polymer DES may trump biodegradable stents ()
Sweet tooth may prove deadly to cardiovascular systems ()
Newborn pulse ox screening may help detect heart defects earlier ()
Longer wait times indicate increased demand for cardiologists ()
Ablation tech chief retires as part of St. Jude integration ()
FDA scrutinizing testosterone products ()
Valiant Captivia Thoracic Stent Graft System from Medtronic receives FDA approval for treating aortic dissections ()
Preventive Cardiovascular Nurses Association and Measure Up/Pressure Down(TM) join together to combat high blood pressure ()
Baptist Foundation awards grant to AMGA's Measure Up/Pressure Down(TM) campaign ()
St. Jude Medical gains CE Mark for 25 mm Portico Transcatheter Aortic Heart Valve ()
Amgen announces positive top-line results from Phase 3 RUTHERFORD-2 Trial Of Evolocumab (AMG 145) in patients with heterozygous familial hypercholesterolemia ()
Amgen announces positive top-line results from Phase 3 LAPLACE-2 Trial Of Evolocumab (AMG 145) in combination with statins in patients with high cholesterol ()
iRhythm announces that ZIO(r) Service included under new Aetna policy covering long-term continuous monitoring of patients with suspected heart arrhythmias ()
Israel Ministry of Health approves clinical trials for BioControl Medical's CardioFit(r) System in heart failure ()
Beaumont Health System first outside of Japan to test new atrial fibrillation technology ()